Sponsor: ECOG-ACRIN Cancer Research Group
Sponsor Study ID: EA1183
Study Title: FDG PET to Assess Therapeutic Response in Patients With Bone Dominant Metastatic Breast Cancer, FEATURE
CTO #: 103321
NCT Number: NCT04316117
Phase: II
Protocol Type: Diagnostic
Age Group: Adults
Disease Sites: Breast
Study Objectives: This phase II trial studies how well FDG-PET/CT works in assessing the response of patients with breast cancer that has spread to the bones or mostly to the bones (bone-dominant metastatic breast cancer). Diagnostic procedures, such as FDG-PET/CT, may work better in measuring breast cancer activity before and after treatment compared to other standard imaging tests.